Psoriasis is an immune-mediated disease that can affect the skin and joints. Skin manifestations include thickened plaques that often have overlying silver scale and are itchy. Psoriasis is characterized by systemic inflammation and up to 20 to 30 percent of people affected have or will develop arthritis. Additionally, patients with psoriasis have a higher risk of developing metabolic syndrome and heart disease. The treatment of psoriasis is guided by the extent of skin involvement and the presence of joint involvement and may include:

  • Topical steroids (clobetasol, betamethasone)
  • Vitamin D topical creams: Dovonex® (calcipotriene)
  • Combination topicals: Taclonex® (calcipotriene/betamethasone)
  • Oral immunomodulation treatments: methotrexate, cyclosporine
  • Biologic treatments: Humira® (adalimumab), Enbrel® (etanercept), Stelara® (ustekinumab), Otezla® (apremilast)
  • Oral or topical retinoids: Soriatane® (acitretin), Tazorac® (tazarotene)
  • Phototherapy
Dr. Verebelyi is a member of ASLMS, ABVLM, AAFP and Mensa

Dr. Verebelyi is a nationally recognized authority on laser surgery. He is board certified by both the American Board of Family Practice and The American Board of Venous & Lymphatic Medicine. Dr. Verebelyi helped create the Fundamentals of Laser Surgery course given by American Society of Laser Medicine & Surgery (ASLMS) where he has worked as both a director and instructor. He is a Fellow at the ASLMS, member of the American College of Phlebology and a member of Mensa.

May Special Offers

Save with Colorado Skin & Vein